IL1F10 and dermatitis: Subcutaneous injections of IL-38 in the back skin of WT mice ameliorated the symptoms of Aldara (5% IMQ)-induced skin inflammation by decreasing acanthosis, scale thickness and dermal inflammatory infiltrate (124).